Final analysis of a randomized phase II trial with prednisone, vinblastine, doxorubicin, and gemcitabine in patients with early unfavorable Hodgkin lymphoma -PVAG-14 pilot

MLA

Fuchs, M., et al. Final Analysis of a Randomized Phase II Trial with Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Patients with Early Unfavorable Hodgkin Lymphoma -PVAG-14 Pilot. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1364943390&authtype=sso&custid=ns315887.

APA

Fuchs, M., Wongso, D., Pluetschow, A., Feuring-Buske, M., Hertenstein, B., Hoeffkes, H.-G., Vogelhuber, M., von Tresckow, B., Biersack, H., Link, H., Topp, M. S., Fischer, N., Bredenfeld, H., Sasse, S., Behringer, K., Boell, B., Borchmann, P., & Engert, A. (2014). Final analysis of a randomized phase II trial with prednisone, vinblastine, doxorubicin, and gemcitabine in patients with early unfavorable Hodgkin lymphoma -PVAG-14 pilot.

Chicago

Fuchs, M., D. Wongso, A. Pluetschow, M. Feuring-Buske, B. Hertenstein, H. -G Hoeffkes, M. Vogelhuber, et al. 2014. “Final Analysis of a Randomized Phase II Trial with Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Patients with Early Unfavorable Hodgkin Lymphoma -PVAG-14 Pilot.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1364943390&authtype=sso&custid=ns315887.